Patent details
EP1915151 Title: COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS
Basic Information
- Publication number:
- EP1915151
- PCT Application Number:
- PCT/US/2006/010582
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067393983
- PCT Publication Number:
- WO/2006/102504
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS
- French Title of Invention:
- COMBINAISONS DESTINEES AU TRAITEMENT DE CANCER COMPRENANT ANTICORPS ANTI-EGFR INHIBITEURS VEGFR
- German Title of Invention:
- ANTI-EGFR-ANTIKÖRPER UND VEGFR-INHIBITOREN UMFASSENDE KOMBINATIONEN FÜR DIE BEHANDLUNG VON KREBS
- SPC Number:
Dates
- Filing date:
- 22/03/2006
- Grant date:
- 17/08/2011
- EP Publication Date:
- 17/08/2011
- PCT Publication Date:
- 28/09/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/04/2008
- EP B1 Publication Date:
- 17/08/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 22/03/2012
- Expiration date:
- 22/03/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/03/2006
- Name:
- Amgen Inc
- Address:
- Patent Operations, M/S 28-2-C One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)
Inventor
- Name:
- CHANG David
- Address:
- United States (US)
Priority
- Priority Number:
- 664381 P
- Priority Date:
- 22/03/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/444;
| Filing date | Document type | Number of pages |
|---|